Proteomic profiling of carbonic anhydrase CA3 in skeletal muscle.

Aging CA3 biomarker carbonic anhydrase denervation dystrophinopathy muscle damage muscle degeneration muscular dystrophy sarcopenia of old age

Journal

Expert review of proteomics
ISSN: 1744-8387
Titre abrégé: Expert Rev Proteomics
Pays: England
ID NLM: 101223548

Informations de publication

Date de publication:
12 2021
Historique:
pubmed: 11 12 2021
medline: 3 2 2022
entrez: 10 12 2021
Statut: ppublish

Résumé

Carbonic anhydrase (CA) is a key enzyme that mediates the reversible hydration of carbon dioxide. Skeletal muscles contain high levels of the cytosolic isoform CA3. This enzyme has antioxidative function and plays a crucial role in the maintenance of intracellular pH homeostasis. Since elevated levels of serum CA3, often in combination with other muscle-specific proteins, are routinely used as a marker of general muscle damage, it was of interest to examine recent analyses of this enzyme carried out by modern proteomics. This review summarizes the mass spectrometry-based identification and evaluation of CA3 in normal, adapting, dystrophic, and aging skeletal muscle tissues. The mass spectrometric characterization of CA3 confirmed this enzyme as a highly useful marker of both physiological and pathophysiological alterations in skeletal muscles. Cytosolic CA3 is clearly enriched in slow-twitching type I fibers, which makes it an ideal marker for studying fiber type shifting and muscle adaptations. Importantly, neuromuscular diseases feature distinct alterations in CA3 in skeletal muscle tissues versus biofluids, such as serum. Characteristic changes of CA3 in age-related muscle wasting and dystrophinopathy established this enzyme as a suitable biomarker candidate for differential diagnosis and monitoring of disease progression and therapeutic impact.

Identifiants

pubmed: 34890519
doi: 10.1080/14789450.2021.2017776
doi:

Substances chimiques

Muscle Proteins 0
Carbonic Anhydrases EC 4.2.1.1

Types de publication

Journal Article Research Support, Non-U.S. Gov't Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

1073-1086

Auteurs

Paul Dowling (P)

Department of Biology, Maynooth University, National University of Ireland, Maynooth, Ireland.
Kathleen Lonsdale Institute for Human Health Research, Maynooth University, Maynooth, Ireland.

Stephen Gargan (S)

Department of Biology, Maynooth University, National University of Ireland, Maynooth, Ireland.
Kathleen Lonsdale Institute for Human Health Research, Maynooth University, Maynooth, Ireland.

Margit Zweyer (M)

Department of Neonatology and Pediatric Intensive Care, Children's Hospital, University of Bonn, Bonn, Germany.

Hemmen Sabir (H)

Department of Neonatology and Pediatric Intensive Care, Children's Hospital, University of Bonn, Bonn, Germany.

Dieter Swandulla (D)

Institute of Physiology, University of Bonn, Bonn, Germany.

Kay Ohlendieck (K)

Department of Biology, Maynooth University, National University of Ireland, Maynooth, Ireland.
Kathleen Lonsdale Institute for Human Health Research, Maynooth University, Maynooth, Ireland.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH